Fangxin Li

Fangxin Li is an experienced investor and board member in the healthcare and biotech sectors, currently serving as an Investor at WuXi AppTec since April 2021, focusing on incubating and managing a diverse portfolio of over 15 companies. Additionally, Fangxin is a Member of the Board of Directors at Hua Medicine since October 2023. Previous roles include Consultant at Bain & Company, emphasizing healthcare strategy and commercial due diligence, and Founding CEO at HAIKUI Regenerative Medicine, where innovations in cartilage implants and dermal fillers were advanced to preclinical stages. Fangxin holds a Ph.D. in Tissue Engineering from the University of Oxford and a Bachelor of Engineering from Imperial College London.